Acquiring Company
AbbVie Inc.
Acquired Company
AbbVie Inc.
North ChicagoNorth ChicagoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaDescription
AbbVie, Inc. has acquired Cerevel Therapeutics Holdings, Inc. for $45.00 per share. The acquisition was announced following Cerevel's public stock offering conducted two months prior. This acquisition marks a significant move for AbbVie into the neuroscience field. Entwistle & Cappucci is investigating potential securities law violations related to this acquisition.
Quick answer
AbbVie Inc. is acquiring AbbVie Inc., announced March 31, 2025. AbbVie Inc. is based in North Chicago, Illinois, United States.
- Who acquired AbbVie Inc?
- AbbVie Inc. agreed to acquire AbbVie Inc. on March 31, 2025.
- How much did AbbVie Inc. pay for AbbVie Inc?
- The deal value was not disclosed.
- Where are AbbVie Inc. and AbbVie Inc. based?
- AbbVie Inc. is based in North Chicago, Illinois, United States. AbbVie Inc. is based in North Chicago, Illinois, United States.
- Who are the decision-makers at AbbVie Inc?
- Fundz holds 2 contacts at AbbVie Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Cerevel for $45 per share (April 15, 2025)
- AbbVie to acquire Cerevel Therapeutics for $45/share (April 7, 2025)
- GSK completes acquisition of IDRx, Inc. to enhance precision therapeutics for treating gastrointestinal stromal tumours (February 24, 2025)
- OS Therapies completes acquisition of Advaxis assets from Ayala Pharmaceuticals (April 12, 2025)
- Roquette acquires IFF Pharma Solutions for growth (May 5, 2025)
- Apnimed acquires global rights to sulthiame (April 25, 2025)
Who to call at AbbVie Inc., and when
When AbbVie Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired AbbVie Inc.?
AbbVie Inc. was acquired by AbbVie Inc., based in North Chicago. The deal was reported on March 31, 2025. Venture capital subsidiary of Abbvie AbbVie Inc. is publicly traded (ABBV) and operates in Manufacturing.
When did AbbVie Inc. acquire AbbVie Inc.?
AbbVie Inc.'s acquisition of AbbVie Inc. was reported on March 31, 2025. AbbVie, Inc. has acquired Cerevel Therapeutics Holdings, Inc. for $45.00 per share. The acquisition was announced following Cerevel's public stock offering conducted two months prior. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does AbbVie Inc. do?
Venture capital subsidiary of Abbvie It is publicly traded (ABBV), operating in Manufacturing, and is based in North Chicago.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.